AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Bls Pharmaceuticals Limited

1.060

+0.14015.22%

Volume:1.36M

Turnover:1.38M

Market Cap:243.78M

PE:26.58

High:1.075

Open:0.940

Low:0.930

Close:0.920

52wk High:1.075

52wk Low:0.760

Shares:229.98M

Float Shares:- -

Volume Ratio:7.87

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.040

EPS(LYR):0.023

ROE:66.14%

ROA:24.99%

PB:12.09

PE(LYR):46.09

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

BLS Pharmaceuticals Sees FY27 Adjusted. Ebitda Margin 23% - 26%

BLS Pharmaceuticals Posts FY Net Profit After Tax of A$15.4 MLN

Bls Pharmaceuticals - no Dividends Have Been Paid or are Proposed

THOMSON REUTERS

Bls Pharmaceuticals - FY Revenue A$74.2 Million

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/BLS.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BLS.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BLS.AU\",,,,,undefined,":{"symbol":"BLS.AU","market":"AU","secType":"STK","nameCN":"Bls Pharmaceuticals Limited","latestPrice":1.06,"timestamp":1788156720000,"preClose":0.92,"halted":0,"volume":1360284,"delay":0,"changeRate":0.15217391304347827,"nameEN":"Bls Pharmaceuticals Limited","floatShares":0,"shares":229978083,"eps":0.039883,"marketStatus":"Not Yet Opened","change":0.14,"latestTime":"08-31 16:12:00 AEST","open":0.94,"high":1.075,"low":0.93,"amount":1376479,"amplitude":0.157609,"askPrice":1.07,"askSize":29984,"bidPrice":1.05,"bidSize":10000,"shortable":3,"etf":0,"ttmEps":0.039883,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1788220800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.92,"openAndCloseTimeList":[[1788134400000,1788156000000]],"volumeRatio":7.867361,"lotSize":0,"tradeCurrency":"AUD","auctionPricing":{"symbol":"BLS.AU","preClose":0.92,"auctionPrice":1.06,"auctionVolume":49410,"auction":3,"marketStatus":"盘后竞价","timestamp":1788156601003}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BLS.AU\",,,,,undefined,":{"symbol":"BLS.AU","floatShares":0,"roa":"24.99%","roe":"66.14%","lyrEps":0.023,"volumeRatio":7.867361,"shares":229978083,"dividePrice":0,"high":1.075,"amplitude":0.157609,"preClose":0.92,"low":0.93,"week52Low":0.76,"pbRate":"12.09","psRate":"5.08","week52High":1.075,"institutionHeld":0,"latestPrice":1.06,"committee":-0.4998,"eps":0.039883,"divideRate":0,"volume":1360284,"delay":0,"ttmEps":0.039883,"open":0.94,"prevYearClose":0.955,"prevWeekClose":0.92,"prevMonthClose":0.81,"prevQuarterClose":0.955,"fiveDayClose":0.93,"twentyDayClose":0.83},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BLS.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-31","symbol":"BLS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1788134400000,"name":null,"time":"","dateTimestamp":1788098400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BLS.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BLS.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2663078746","title":"BLS Pharmaceuticals Sees FY27 Adjusted. Ebitda Margin 23% - 26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663078746","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663078746?lang=en_us&edition=fundamental","pubTime":"2026-08-31 15:50","pubTimestamp":1788162639,"startTime":"0","endTime":"0","summary":"BRIEF-BLS Pharmaceuticals Sees FY27 Adjusted. EBITDA Margin 23% - 26%Aug 31 (Reuters)-BLS Pharmaceuticals LtdBLS.AX:SEES FY27 ADJUSTED. EBITDA MARGIN 23% - 26%SEES FY27 REVENUE A$105M – A$115MFurther company coverage:BLS.AX","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R03G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7048","BLS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663902933","title":"BLS Pharmaceuticals Posts FY Net Profit After Tax of A$15.4 MLN","url":"https://stock-news.laohu8.com/highlight/detail?id=2663902933","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663902933?lang=en_us&edition=fundamental","pubTime":"2026-08-31 10:41","pubTimestamp":1788144097,"startTime":"0","endTime":"0","summary":"BRIEF-BLS Pharmaceuticals Posts FY Net Profit After Tax Of A$15.4 MLNAug 31 (Reuters)-BLS Pharmaceuticals LtdBLS.AX:FY REVENUE A$74.2 MILLIONFY NET PROFIT AFTER TAX OF A$15.4 MILLIONNO DIVIDENDS HAVE BEEN PAID OR ARE PROPOSEDFurther company coverage:BLS.AX","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R00O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7048","BLS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663298400","title":"Bls Pharmaceuticals - no Dividends Have Been Paid or are Proposed","url":"https://stock-news.laohu8.com/highlight/detail?id=2663298400","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663298400?lang=en_us&edition=fundamental","pubTime":"2026-08-31 10:39","pubTimestamp":1788143995,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R00P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7048","BLS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663029828","title":"Bls Pharmaceuticals - FY Revenue A$74.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2663029828","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663029828?lang=en_us&edition=fundamental","pubTime":"2026-08-31 10:39","pubTimestamp":1788143946,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R00O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BLS.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/BLS.AU\",params:#limit:6,delay:true,,,undefined,":[]}}